RAUL CARRIL: Open Payments
NPI 1265481964 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$348 in 16 payments from 10 companies in 2025. Trend: 2023 $412 · 2024 $409 · 2025 $348
Food & beverage: $348
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 4 | $97 |
| Abbott Laboratories | 2 | $43 |
| Collegium Pharmaceutical, Inc. | 2 | $41 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| PROTEGA PHARMACEUTIALS INC | 1 | $34 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $25 |
| Medtronic, Inc. | 1 | $22 |
| Averitas Pharma Inc. | 1 | $19 |
| SCILEX PHARMACEUTICALS INC. | 1 | $19 |
| Curonix LLC | 1 | $15 |
Products named: WaveWriter Alpha Prime 16, RELISTOR, ROXYBOND, JOURNAVX, Belbuca, OCTRODE, SYNCHROMEDII, ETERNA.
Industry payments across FL — which companies pay providers there.
